These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Problems and achievements of modern clinical cardiology]. Teodori MI Voen Med Zh; 1972 Aug; 8():22-9. PubMed ID: 4565106 [No Abstract] [Full Text] [Related]
3. [Current theories on the role of hyperuricemia as one of the risk factors in ischemic heart disease]. Mamasaliev NS; Tursunov SIu; Nabieva AF Ter Arkh; 1980; 52(10):132-5. PubMed ID: 7003789 [No Abstract] [Full Text] [Related]
8. Coronary atherosclerosis. 3. Development of hypertension, hypercholesterolemia and coronary artery lipid deposits in the adult virgin female Wister rat. Eades CH; Phillips GE; Blaustein A; Hsu IC; Solberg VB; Ekholm CA; Harrsch F Angiologica; 1966; 3(5):269-78. PubMed ID: 5957695 [No Abstract] [Full Text] [Related]
9. [Lipid metabolism disorder: detection and treatment. 5: Treatment of hyperlipidemia in manifest coronary heart disease, diabetes mellitus and hypertension. National cholesterol initiative]. Assmann G Fortschr Med; 1991 Jun; 109(17):361-3. PubMed ID: 1885117 [No Abstract] [Full Text] [Related]
10. [The role of disorders of lipid metabolism in the appearance of complications in the course of essential arterial hypertension]. Brauner R; Panaitescu G; Demayo A Med Interna (Bucur); 1969 May; 21(5):619-23. PubMed ID: 5344556 [No Abstract] [Full Text] [Related]
11. [Myocardial injury and phospholipases]. Okamoto M; Tojo H Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1871-8. PubMed ID: 2236601 [No Abstract] [Full Text] [Related]
12. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824 [No Abstract] [Full Text] [Related]
13. Coronary heart disease: hypertension and other risk factors. Proceedings of a satellite symposium of the first European Meeting on Hypertension. Am J Med; 1984 Feb; 76(2A):1-124. PubMed ID: 6702858 [No Abstract] [Full Text] [Related]
15. [Contractile function of the heart and myocardial lipid metabolism during measured restriction of coronary blood supply]. Orlova NN; Garkusha LN; Bratus' VV Fiziol Zh (1978); 1981; 27(5):617-22. PubMed ID: 7297710 [No Abstract] [Full Text] [Related]
16. [Relations between the seasonal changes in the myocardial contraction and various indices of lipid metabolism in damaged myocardium]. Frolov VA; Efimov LV Biull Eksp Biol Med; 1982 Oct; 94(10):20-2. PubMed ID: 7171793 [No Abstract] [Full Text] [Related]
17. Lipid metabolism in the normoxic and ischaemic heart. Proceedings of an international symposium. Rotterdam, The Netherlands, September 22 and 23, 1986. Basic Res Cardiol; 1987; 82 Suppl 1():1-269. PubMed ID: 3663001 [No Abstract] [Full Text] [Related]
18. [On balneotherapy of patients with hypertension with coronary circulation disorders]. Giandzhetsian NR Vopr Kurortol Fizioter Lech Fiz Kult; 1965; 30(3):270-2. PubMed ID: 5881828 [No Abstract] [Full Text] [Related]
19. [Pathogenesis and various clinical problems of cardiomyopathy in diabetes mellitus]. Walasik L; Tatoń J Pol Tyg Lek; 1985 Mar; 40(10):317-22. PubMed ID: 3889882 [No Abstract] [Full Text] [Related]
20. [Achievements and perspectives of development of cardiology in Uzbekistan]. Abdullaev RA Ter Arkh; 1974; 46(6):105-10. PubMed ID: 4279460 [No Abstract] [Full Text] [Related] [Next] [New Search]